Trowbridge, Angiodynamics CFO, buys $9,932 in stock
PositiveFinancial Markets

In a notable move, Trowbridge, the CFO of Angiodynamics, has purchased nearly $10,000 worth of stock in the company. This investment signals confidence in Angiodynamics' future prospects and could encourage other investors to consider the company's potential. Such insider buying often reflects a positive outlook on the company's performance, making it a significant development for stakeholders.
— Curated by the World Pulse Now AI Editorial System